D349E variant in HCM patients, and the variant promotes cardiac hypertrophy by activating the cGAS-STING-IFN pathway.48 However, there are few reports about the effect of Nap1L1 in cardiomyocytes in response to I/R. The gene discussed is NAP1L1; the disease is cardiac hypertrophy.